TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)

TELCON RF PHARMACEUTICAL. Revenue

TELCON RF PHARMACEUTICAL. had revenue of 28.94B KRW in the quarter ending June 30, 2026, with 188.49% growth. This brings the company's revenue in the last twelve months to 61.78B, up 50.63% year-over-year. In the year 2025, TELCON RF PHARMACEUTICAL. had annual revenue of 43.16B with 13.99% growth. That makes TELCON RF PHARMACEUTICAL. the 28,508th largest company in the world by revenue and 1,745th in South Korea.

• Revenue (ttm): 61.78B
• Revenue Growth: +50.63%
• P/S Ratio: 0.21
• Revenue / Employee: 490.35M
• Employees: 126
• Market Cap: 12.73B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	43.16B	5.30B	13.99%
Dec 31, 2024	37.87B	1.56B	4.29%
Dec 31, 2023	36.31B	8.48B	30.46%
Dec 31, 2022	27.83B	-10.01B	-26.46%
Dec 31, 2021	37.84B	4.70B	14.18%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 4, 2026

Data Sources Report a data error